<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: Serrated <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> (hyperplastic <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e>) is characterized by multiple <z:mpath ids='MPATH_491'>polyps</z:mpath> with serrated architecture in the colorectum </plain></SENT>
<SENT sid="1" pm="."><plain>Although patients with serrated <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> are known to be at increased risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and possibly extracolonic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk for their relatives has not been widely explored </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to estimate the risks of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and extracolonic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> for relatives of patients with serrated <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: A cohort of the 1,639 first- and second-degree relatives of 100 index patients with serrated <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> recruited regardless of a family history of <z:mpath ids='MPATH_491'>polyps</z:mpath> or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> from genetic clinics in Australia, New Zealand, Canada, and the USA, were retrospectively analyzed to estimate the country-, age-, and sex-specific standardized incidence ratios (SIRs) for relatives compared with the general population </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A total of 102 CRCs were observed in first- and second-relatives (SIR 2.25, 95% confidence interval (CI) 1.75-2.93; P&lt;0.001), with 54 in first-degree relatives (SIR 5.16, 95% CI 3.70-7.30; P&lt;0.001) and 48 in second-degree relatives (SIR 1.38, 95% CI 1.01-1.91; P=0.04) </plain></SENT>
<SENT sid="5" pm="."><plain>Six <z:hpo ids='HP_0002894'>pancreatic cancers</z:hpo> were observed in first-degree relatives (SIR 3.64, 95% CI 1.70-9.21; P=0.003) </plain></SENT>
<SENT sid="6" pm="."><plain>There was no statistical evidence of increased risk for <z:e sem="disease" ids="C0024623,C0699791" disease_type="Neoplastic Process" abbrv="">cancer of the stomach</z:e>, brain, breast, or prostate </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Our finding that relatives of serrated <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> patients are at significantly increased risk of colorectal and <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> adds to the accumulating evidence that serrated <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> has an inherited component </plain></SENT>
</text></document>